We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
High Tide (HITI) announces the acquisition of Queen of Bud to boost its in-house cannabis brand portfolio without burdening its significant capital expenditure.
Labcorp's (LH) new research shows how biomarker testing can help close testing gaps and guide tailored therapy for patients with epithelial ovarian cancer.
GE HealthCare's (GEHC) evolution of its AI collaboration is likely to lead to digital and AI transformation and provide better patient care and outcomes.
Edwards Lifesciences (EW) outperforms the industry, owing to a robust 2023 fourth-quarter performance, as well as the strong potential in the TMTT division.
Charles River's (CRL) partnership with Navega Therapeutics will enable it to leverage its strong AAV portfolio and leading gene therapy CDMO capabilities.
Intuitive Surgical (ISRG) announces the FDA clearance for its next-generation robotic system, da Vinci 5, which is likely to improve surgical workflow and save significant time with better care.
Axonics' (AXNX) fourth-generation rechargeable Sacral Neuromodulation system will reduce the frequency of patient recharges significantly. The new form factor ensures ease of use.
BD's (BDX) ADC system is likely to result in improvements in clinical workflow, operational efficiency and financial savings in long-term care facilities.
Inari Medical (NARI) announces two-year interim results from the CLOUT registry, which shows a significant improvement in patient's post-thrombotic syndrome and lower rethrombosis-related events.
A cyberattack on UnitedHealth's (UNH) payment management subsidiary, Change Healthcare, last month continues to impact healthcare services, especially cancer treatments, as payment processing remains disrupted.
medical-devices: Archive
Here's Why You Should Retain Inspire Medical (INSP) Stock Now
by Zacks Equity Research
Inspire Medical's (INSP) focus on R&D raises optimism about the stock.
DVAPositive Net Change CAHNegative Net Change CORPositive Net Change INSPPositive Net Change
medical medical-devices
Revvity's (RVTY) New Launch to Boost Newborn Sequencing Research
by Zacks Equity Research
Revvity's (RVTY) next-generation newborn sequencing research workflow is likely to build the foundation for diagnosing rare diseases in the future.
DVAPositive Net Change CAHNegative Net Change CORPositive Net Change RVTYNegative Net Change
medical medical-devices
High Tide (HITI) Acquires Queen of Bud to Expand Its Portfolio
by Zacks Equity Research
High Tide (HITI) announces the acquisition of Queen of Bud to boost its in-house cannabis brand portfolio without burdening its significant capital expenditure.
DVAPositive Net Change CAHNegative Net Change CORPositive Net Change HITINegative Net Change
medical medical-devices
Chemed (CHE) Reaches a New 52-Week High: What's Driving It?
by Zacks Equity Research
Investors are optimistic about Chemed (CHE) on strong performance across the VITAS and Roto-Rooter segments.
SYKPositive Net Change DVAPositive Net Change CAHNegative Net Change CHEPositive Net Change
medical medical-devices
Labcorp (LH) Presents New Research on Precision Diagnostics
by Zacks Equity Research
Labcorp's (LH) new research shows how biomarker testing can help close testing gaps and guide tailored therapy for patients with epithelial ovarian cancer.
LHPositive Net Change SYKPositive Net Change CAHNegative Net Change CORPositive Net Change
medical medical-devices
Reasons to Retain DexCom (DXCM) Stock in Your Portfolio for Now
by Zacks Equity Research
DexCom (DXCM) continues to raise optimism among investors, owing to its strong product portfolio.
DVAPositive Net Change CAHNegative Net Change DXCMPositive Net Change CORPositive Net Change
medical medical-devices
Here's Why You Should Buy Insulet (PODD) Stock Right Now
by Zacks Equity Research
Investors remain confident in the Insulet (PODD) stock due to the huge success of Omnipod 5.
SYKPositive Net Change DVAPositive Net Change CAHNegative Net Change PODDPositive Net Change
medical medical-devices
Exact Sciences' (EXAS) BLUE-C Study Results Published in NEJM
by Zacks Equity Research
Exact Sciences (EXAS) announces the publication of the BLUE-C study results in The New England Journal of Medicine.
SYKPositive Net Change DVAPositive Net Change CAHNegative Net Change EXASPositive Net Change
medical medical-devices
GE HealthCare (GEHC) Advances AI Alliance to Improve Workflow
by Zacks Equity Research
GE HealthCare's (GEHC) evolution of its AI collaboration is likely to lead to digital and AI transformation and provide better patient care and outcomes.
DVAPositive Net Change CAHNegative Net Change CORPositive Net Change GEHCPositive Net Change
medical medical-devices
Edwards Lifesciences (EW) Hits 52-Week High: What's Driving It?
by Zacks Equity Research
Edwards Lifesciences (EW) outperforms the industry, owing to a robust 2023 fourth-quarter performance, as well as the strong potential in the TMTT division.
SYKPositive Net Change DVAPositive Net Change CAHNegative Net Change EWPositive Net Change
medical medical-devices
Charles River (CRL) Extends Gene Therapy Offering With New Pact
by Zacks Equity Research
Charles River's (CRL) partnership with Navega Therapeutics will enable it to leverage its strong AAV portfolio and leading gene therapy CDMO capabilities.
SYKPositive Net Change CAHNegative Net Change CRLPositive Net Change CORPositive Net Change
medical medical-devices
Intuitive Surgical's (ISRG) Da Vinci 5 Receives FDA Approval
by Zacks Equity Research
Intuitive Surgical (ISRG) announces the FDA clearance for its next-generation robotic system, da Vinci 5, which is likely to improve surgical workflow and save significant time with better care.
ISRGNegative Net Change DVAPositive Net Change CAHNegative Net Change CORPositive Net Change
medical medical-devices
Waters (WAT) Boosts Portfolio Strength With Rheo-IS Accessory
by Zacks Equity Research
Waters (WAT) unveils Rheo-IS accessory for its TA Instruments Discovery Hybrid Rheometers, bolstering its overall portfolio.
DVAPositive Net Change WATNegative Net Change CAHNegative Net Change ICLRNegative Net Change
medical medical-devices
Should You Buy The RealReal (REAL) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
REALNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Should You Buy Airgain (AIRG) After Golden Cross?
by Zacks Equity Research
When a stock experiences a golden cross technical event, good things could be on the horizon. How should investors react?
AIRGNegative Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Axonics (AXNX) Gets CE Mark for Sacral Neuromodulation System
by Zacks Equity Research
Axonics' (AXNX) fourth-generation rechargeable Sacral Neuromodulation system will reduce the frequency of patient recharges significantly. The new form factor ensures ease of use.
BSXPositive Net Change DVAPositive Net Change CAHNegative Net Change AXNXPositive Net Change
medical medical-devices
Reasons to Hold West Pharmaceutical (WST) in Your Portfolio Now
by Zacks Equity Research
West Pharmaceutical (WST) continues to gain momentum due to its strength in the Proprietary Products business. However, forex concerns persist.
DVAPositive Net Change CAHNegative Net Change WSTPositive Net Change BDSXNegative Net Change
medical medical-devices
BD's (BDX) ADC System Favored by New Study for Long-Term Care
by Zacks Equity Research
BD's (BDX) ADC system is likely to result in improvements in clinical workflow, operational efficiency and financial savings in long-term care facilities.
BDXPositive Net Change DVAPositive Net Change CAHNegative Net Change CORPositive Net Change
medical medical-devices
Inari Medical's (NARI) ClotTriever Improves Patient Outcome
by Zacks Equity Research
Inari Medical (NARI) announces two-year interim results from the CLOUT registry, which shows a significant improvement in patient's post-thrombotic syndrome and lower rethrombosis-related events.
DVAPositive Net Change CAHNegative Net Change CORPositive Net Change NARIPositive Net Change
medical medical-devices
Should You Buy Criteo S.A. (CRTO) After Golden Cross?
by Zacks Equity Research
Is it a good or bad thing when a stock experiences a golden cross technical event?
CRTOPositive Net Change
ad-tech artificial-intelligence automation autonomous-vehicles batteries biotechnology cell-therapy creator-economy crispr daily-movers dna-sequencing electric-vehicles fin-tech furniture-retailers gambling gene-editing gene-therapy genetic-testing genomics home-builder home-buying-apps immuno-therapy iot medical-devices messenger-rna mobile moving-average-crossover oncology-screening payments ride-hailing robotics saas self-driving-cars smart-health social-media stock-price-movement stocks-moving-today vaccines
Buy 5 Medical Devices Stocks for a Stable Portfolio in 2024
by Nalak Das
We have narrowed our search to five Medical Instruments stocks with strong potential for 2024. These are: AORT, TMDX, DXCM, SWAV, EW.
EWPositive Net Change DXCMPositive Net Change SWAVPositive Net Change TMDXNegative Net Change AORTPositive Net Change
medical-devices
Here's Why You Should Retain Charles River (CRL) Stock Now
by Zacks Equity Research
Investors remain optimistic about Charles River (CRL) due to the strength of the RMS segment.
SYKPositive Net Change DVAPositive Net Change CAHNegative Net Change CRLPositive Net Change
medical medical-devices
Bruker (BRKR) Up 20.7% Since Last Earnings: What's Driving It?
by Zacks Equity Research
Investors are upbeat about Bruker (BRKR) led by strong NANO group prospects and strong guidance.
SYKPositive Net Change CAHNegative Net Change CORPositive Net Change BRKRNegative Net Change
medical medical-devices
Chemed's (CHE) VITAS Segment Inks New Deal With Covenant Care
by Zacks Equity Research
Chemed's (CHE) VITAS segment is set to acquire the hospice assets of Covenant Care in Florida and Alabama.
SYKPositive Net Change DVAPositive Net Change CAHNegative Net Change CHEPositive Net Change
medical medical-devices
UnitedHealth's (UNH) Payment System Disrupted by Cyberattack
by Zacks Equity Research
A cyberattack on UnitedHealth's (UNH) payment management subsidiary, Change Healthcare, last month continues to impact healthcare services, especially cancer treatments, as payment processing remains disrupted.
UNHNegative Net Change CAHNegative Net Change MCKNegative Net Change CORPositive Net Change
medical medical-devices